Pharma Co Ipca Labs Acquires UK-based Onyx Research Chem For Rs 34Cr

09 August, 2011

Mumbai-based pharmaceutical company Ipca Laboratories Ltd has acquired 100 per cent stake in Onyx Research Chemicals, the holding company of Onyx Scientific Ltd, according to a company statement. The acquisition of Onyx, a UK-based pharmaceutical service firm, has been done through its wholly owned subsidiary Ipca Laboratories, UK, for £4.6 million or Rs 34 crore.

Onyx Scientific has been a chemistry solutions provider for over a decade and will continue to operate out of Silverbriar (Sunderland, UK) under the trade name of Onyx Scientific. Onyx, founded in 2000, is a supplier to large pharma and biotech firms. It offers custom synthesis, solid state chemistry, scale up and cGMP manufacturing.

Onyx Scientific had a total income of £3.85 million (Rs 28.45 crore), with an EBIDTA margin of 17 per cent at £0.65 million (Rs 4.8 crore) for its financial year ending March 31, 2011.

“Its capabilities in chemistry services for medicinal, preclinical and phase I/II programmes will dovetail effectively with Ipca’s capabilities in supporting Phase II to commercially scale up programmes,” a statement from Ipca said.

The share price of Ipca was trading on the BSE at Rs 324.9 per unit, marginally up 1.21 per cent at 12:41 pm.

Ipca has recently reported 26.8 per cent increase in its Q1FY12 revenues to Rs 529.9 crore, with profit after tax coming at Rs 61.7 crore.

 

 


Leave Your Comment
ChrysCapital-backed Ipca acquiring 50% of Avik for $1M

ChrysCapital-backed Ipca acquiring 50% of Avik for $1M

TEAM VCC 4 years ago
ChrysCapital-backed pharmaceutical major Ipca Laboratories Ltd is acquiring 50 per cent of Gujarat-based Avik Pharmaceuticals Ltd for Rs 6.51 crore (around $1.04 million), the company...
Ipca Labs picks 19% stake in Krebs Biochem, hiking it to 30%; makes open offer

Ipca Labs picks 19% stake in Krebs Biochem, hiking it to 30%; makes open offer

Jasleen Kaur Batra 3 years ago
Mumbai-based Ipca Laboratories Ltd, which manufactures active pharmaceutical ingredients (APIs) and finished dosage forms, has picked close to 19 per cent stake in Krebs Biochemicals...
ChrysCapital acquires stake in pharma company Ipca Labs for $29M

ChrysCapital acquires stake in pharma company Ipca Labs for $29M

Madhav A Chanchani 3 years ago
Private equity major ChrysCapital has picked up stake in drug-maker Ipca Laboratories Ltd from the markets, according to sources familiar with the development. The PE...
No Comments

Pharma Co Ipca Labs Acquires UK-based Onyx Research Chem For Rs 34Cr

Powered by WordPress.com VIP